Searched for
SPARC TECHNICALS
Technical Breakout Stocks: How to trade Lemon Tree Hotels, GSFC and SPARC on Wednesday?Indian market pared gains and closed lower on Tuesday tracking muted cues. The S&P BSE Sensex fell more than 300 points while the Nifty50 c...
Breakout Stocks: Trade setup for The New India Assurance, General Insurance and SPARC which hit 52-week highsStocks that were in focus include names like The New India Assurance Company rose 20%, General Insurance Corporation gained more than 16% a...
Paytm, Polytech India among 10 stocks with RSI trending downThis article explores why 10 stocks have witnessed a decline in RSI and why assessing stock movements based on RSI is crucial. Join us as w...
Big Movers on D-St: What should investors do with SPARC, Sheela Foam and Manappuram Finance?After a long correction, eventually, the stock took support near 162 and bounced back sharply. On Thursday, it rallied over 10% and also fo...
Rekha Jhunjhunwala picks 2% stake in smallcap pharma stockSun Pharma Advanced Research Company (SPARC) is a clinical-stage bio-pharmaceutical company focused on continuously improving standards of ...
Big Movers on D-St: What should investors do with SPARC, Delta Corp and M&M?The short-term texture of the stock is weak but it is trading in an oversold zone. We are of the view that as long as it is trading below R...
Top stocks in focus on 30 October 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
Top ten intraday trading ideas for afternoon trade for Friday, 11 November 2016Asian Paints is a 'Buy' call with a target price of Rs 1,095 and a stop loss of Rs 970 while Tata Motors is a 'Sell' call with a target of ...
Fifteen stocks in focus in Wednesday's tradeIndian markets are expected to trade higher. Here is a list of ten stocks which are likely to remain in focus today.
Tata Elxsi, Emami, Natco Pharma may join F&O listShares of some of these companies have rallied 50% to 190% this year so far. More stocks are qualifying for inclusion in the F&O segment.
Further upside likely in Sun Pharma, stk can hit Rs 1,150: Mitesh ThackerThacker said that Rs 1,100 could be a good short-term target for Sun Pharma. Eventually, this stock can top Rs 1,150, he believes.
- Buy SPARC with a target of Rs 195: Mitesh Thacker
"SPARC is a 'BUY' call with a target of Rs 195 and a stop loss of Rs 169."
- Buy SPARC with a target of Rs 190: Mitesh Thacker
Buy SPARC with a target of Rs 190 and a stoploss of Rs 160: Mitesh Thacker.
'BUY' or 'SELL' ideas from experts for Thursday, December 05, 2013ET Now spoke to various experts and here's what they have to recommend for today's trade.
- Brokers' call: Sun Pharma remains a buy
Morgan Stanley has maintained a ‘Buy’ rating on Sun Pharmaceuticals with an ‘Overweight’ rating with a target price of Rs 1,159.
- Hot stock: Morgan Stanley sees more upside in Sun Pharma
MS has maintained 'Overweight' rating on Sun Pharma and added the stock to “Asia Best Idea”.
- Sun Pharma Advanced Research is looking good: Sandeep Wagle, APTART Technical Advisory Services
Sandeep Wagle, Founder & MD, APTART Technical Advisory Services, in a chat with ET Now talks about Sun Pharma Advanced Research and Piramal...